The Dime
- Episodes
- 309
- Released
- every two weeks
- Latest episode
- Nov 6, 2026
About the podcast
Most cannabis companies won't survive the next three years. The ones that do will have better capital discipline, sharper regulatory reads, and operational frameworks built for compression, not growth. The Dime is where cannabis operators, executives, and investors hear directly from the CEOs and founders making those decisions right now: MSO strategy, state-by-state market dynamics, cultivation and extraction economics, brand positioning, and the financing structures keeping companies alive. Bryan Fields hosts weekly conversations built for operators, not observers.
Episodes 309
Europe's 51st State, EU GMP, and Building Before the Market Arrives ft. Michael Sassano
The expensive decision rarely looks intelligent before the market needs it.Operators can build for the regulations in front of them, or for the direction regulators are already moving. Across global medical …
Show notes
The expensive decision rarely looks intelligent before the market needs it.
Operators can build for the regulations in front of them, or for the direction regulators are already moving. Across global medical cannabis markets, internal labs, stability programs, EU GMP manufacturing, and control of distribution are beginning to separate companies that can scale profitably from those that can only trade product.
This week we sit down with Michael Sassano
- Europe's 51st state
- Pharmaceutical discipline
- EBITDA before volume
Chapters
- 00:00 Schedule III and Europe
- 02:15 Europe as the 51st state
- 07:44 Building for pharmaceutical lead times
- 11:44 What EU GMP changes
- 16:14 Creativity inside the rulebook
- 19:40 Why pharma owns the lab
- 22:50 The economics of internal validation
- 26:34 Could the United States adopt this model
- 28:34 The EU GMP supply shortage
- 32:32 Regulators close the conversion loophole
- 35:23 Distribution consolidation begins
- 39:46 The missing vertical
- 43:25 A country by country strategy
- 46:37 What SOMAI will not do
- 49:42 Why extracts start with full bud
- 51:38 The rules become the moat
- 53:15 Europe as a totality of growth
- 55:21 Where to find Michael
Guest Links
- SOMAÍ Pharmaceuticals website
- Michael Sassano / SOMAÍ on X
- SOMAÍ on Instagram
- SOMAÍ on LinkedIn
- SOMAÍ on Facebook
Our Links
- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Newton Insights — insights for extraction teams
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
How AYRLOOM Built Its Advantage in New York Cannabis ft. Eddie Brennan
A 115-year farm discovered that preserving the legacy meant letting a new crop compete with it.Ayrloom reached Beak & Skiff's revenue scale in three years, then forced the family to reallocate capital, people …
Show notes
A 115-year farm discovered that preserving the legacy meant letting a new crop compete with it.
Ayrloom reached Beak & Skiff's revenue scale in three years, then forced the family to reallocate capital, people, land, and drying space while cannabis regulation kept the businesses legally separate.
The advantage was not cannabis expertise. It was years of beverage manufacturing scars, retail-grade quality systems, and relationships strong enough to survive a crowded New York shelf.
This week we sit down with Eddie Brennan
- Capital behind rapid growth
- Quality before repeat purchase
- Defending premium through compression
Chapters
- 00:00 Sharing one farm across two companies
- 02:18 Cannabis versus apples for space
- 04:24 Three-year growth catches a 115-year business
- 07:33 Growth, cash, and what breaks
- 09:52 Why cannabis expertise is overrated
- 12:09 Beverage scars become an operating advantage
- 15:17 Grocery-grade quality control
- 19:10 Consistency wins repeat purchase
- 21:04 Making cannabis approachable
- 23:43 The reverse gateway claim
- 25:29 Where cannabis beverages belong
- 27:22 Regulation and high-dose drinks
- 30:14 Why Ayrloom stays narrow and deep
- 34:22 Price compression and retail health
- 37:05 When an in-house brand outruns co-manufacturing
- 39:39 What changes in a new market
- 42:10 The pressure of a fifth-generation legacy
- 44:35 Where to find Ayrloom
Guest Links
Our Links
- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Newton Insights — insights for extraction teams
Follow The Dime for more conversations on cannabis business, operations, and international markets.
Share this episode with an operator rethinking their edibles.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal
Federal cannabis reform is supposed to open the same door for everyone. The current market says otherwise.The largest operators do not share one political agenda, and some of the barriers they complain about …
Show notes
Federal cannabis reform is supposed to open the same door for everyone. The current market says otherwise.
The largest operators do not share one political agenda, and some of the barriers they complain about are also widening their moats. As capital markets, international medical standards, and state regulation collide, the operators built for uncertainty may be the ones hardest to dislodge.
This week we sit down with Jay Rosenthal
- Limbo as a moat
- EU GMP advantage
- Regulation's hidden winners
- 00:00 Federal limbo becomes the business model
- 02:17 The reform everyone agrees on
- 03:28 Capital markets and the bigger pond
- 05:35 Six hundred brands and no patience
- 06:55 Why Rochester can move New York
- 09:48 Strong operators become obvious
- 13:40 The cost of crossing state lines
- 16:28 Aurora Curaleaf and scarce EU GMP assets
- 20:26 The Canadian future that did not arrive
- 22:00 What mature industry compliance could bring
- 24:35 Cultivated's nonsecret sauce
- 31:41 Cannabis stigma still follows the operator
- 32:28 Why Cultivated launched membership
- 40:23 Quality media has a real cost
- 41:18 California and New York regulators share a market
- 44:02 Policy goals that fight each other
- 49:06 Competition cooperation and price compression
- 52:25 Where to find Jay and Cultivated
- Jay Rosenthal - Co-Founder and Managing Director of Cultivated Media
- Cultivated Media
- Cultivated events
- Sign up for the Cultivated Daily newsletter
- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Newton Insights — insights for extraction teams
Follow The Dime for more conversations on cannabis business, operations, and international markets.
Share this episode with an operator rethinking their edibles.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What Makes Consumers Buy the Same Edible Again? ft. Kim Sanchez Rael
Fast-acting edibles can command a premium, but labels such as "nano" do not prove the final product works. The larger operating question is whether the formulation improves taste, shelf stability, manufacturing …
Show notes
Fast-acting edibles can command a premium, but labels such as "nano" do not prove the final product works. The larger operating question is whether the formulation improves taste, shelf stability, manufacturing efficiency, and trust at the same time.
This week we sit down with Kim Sanchez Rael
Fast onset economics
The nano problem
Science/ AI and so much moreFast-acting cannabis edibles promise a more predictable experience, but the language on the package does not always tell operators what happens in the final product.
Kim Sanchez Rael, President and CEO of Azuca, breaks down what "fast" should mean, why slow-onset edibles still dominate, and how formulation choices affect taste, stability, curing time, shelf life, and production efficiency. She explains why "nano" is often a measurement or marketing label rather than proof of a better consumer outcome, then offers four questions brands should ask any infusion supplier.
The conversation also moves beyond formulation. Kim describes the economics behind fast-acting products, the role of supplier behavior when production is at risk, the case for a single regulatory framework for the cannabis plant, and why operators cannot build a business that depends on an unpredictable regulatory change.
Topics include:
- The consumer value of predictable onset
- Manufacturing tradeoffs in gummy formulation
- What brands should demand from infusion partners
- Why structured quality systems matter
- How Azuca uses AI inside its team and customer experience
Learn more about Azuca and TiME INFUSION® at https://azuca.co/.
Guest: Kim Sanchez Rael, President and CEO, Azuca
Host: Bryan Fields, The DimeChapters
- 00:01 Why slow-onset edibles still dominate
- 01:47 The economics of fast acting
- 03:56 Can brands claim "fast"?
- 05:56 Predictability and consumer trust
- 08:06 The retail education gap
- 10:24 How Azuca licensing works
- 14:44 Formulation, cannabinoids, and flavor
- 15:30 When "fast" does not feel fast
- 18:18 Onset, peak, and duration
- 20:01 Manufacturing efficiency R&D
- 23:14 Validating infusion science
- 24:43 Why "nano" is a buzzword
- 27:38 The operational cost of change
- 28:24 Four questions for infusion suppliers
- 30:00 Supplier behavior as brand experience
- 32:31 The Fourth of July production rescue
- 33:48 What cannabis still gets wrong
- 34:15 The One Plant Solution
- 37:04 Policy resistance and incrementalism
- 38:41 AI and "Kimothy"
- 41:21 Quality systems and sustainable math
- 44:58 The question Kim wishes people asked
- 45:45 Where to find Azuca
Our Links
- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Eighth Revolution
- Newton Insights — insights for extraction teams
Follow The Dime for more conversations on cannabis business, operations, and international markets.
Share this episode with an operator rethinking their edibles.
Guest Links
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Europe Is Not a Rescue Plan ft. Jamie Pearson
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once.International markets reward specific operating capabilities …
Show notes
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once.
International markets reward specific operating capabilities, not ambition alone. Pharmaceutical standards, reliable supply, disciplined data use, and local market fit determine whether an operator can cross borders without compounding its problems.
This week we sit down with Jamie Pearson
- EU GMP's undervalued strategic value
- Regulation exposes operating weakness
- Matching strength to global markets
On The Dime, host Bryan Fields speaks with Jamie L. Pearson, President and Founder of New Holland Group, about European cannabis expansion, medical cannabis supply chains, and building operations that can succeed across borders.
Key Takeaways- Jamie explains why European medical cannabis markets call for pharmaceutical reliability, consistent supply, and a different operating model from adult-use brands.
- EU GMP (European Union Good Manufacturing Practice) capability can be a strategic asset for cannabis manufacturing and international market entry.
- Match the company's repeatable strengths to local buyers, regulations, and supply chains before choosing a market.
- Prove standard operating procedures (SOPs) and quality controls in another U.S. state before adding language, currency, and cross-border complexity.
- The discussion spans the UK, Germany, Switzerland, Slovenia, Portugal, and Brazil, alongside cannabis data and U.S. hemp regulation.
00:00 Regulation is breaking the data layer
Guest LinksRelated Episode
02:49 Finding trend data upstream
06:24 What EU GMP actually demands
10:19 Why compliant facilities become strategic assets
16:13 Canada-Europe regulatory harmony
19:20 Europe is medical first
25:28 First-mover advantage vs. disciplined execution
27:59 Medical supply rewards repeatability
30:48 Weak operations do not travel
32:24 Switzerland, Slovenia, and Portugal
35:54 Brazil and partner requirements
37:07 Practice expansion before global scale
40:08 The hidden U.S. hemp market
43:29 Turning customers into political force
47:10 Directness as respectGermany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka — continue exploring Germany's cannabis market and operational discipline.
Our Links- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Eighth Revolution
- Newton Insights — insights for extraction teams
Follow The Dime for more conversations on cannabis business, operations, and international markets. Share this episode with an operator considering expansion.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine
Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December. What they may not realize is that the ban could …
Show notes
Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December.
What they may not realize is that the ban could eliminate the full-spectrum therapeutic hemp formulations that helped change America's view of cannabis and are used daily by an estimated 45 million Americans.
The provision was written by two members of Congress, without a conference or regular order, and inserted into a massive spending bill during the longest government shutdown in American history.
What should have been handled with a scalpel was done with a sledgehammer.
This week we sit down with Paige Figi to discuss
• Silence is a position
• The scalpel Congress skipped
• Oval Office, then bannedChapters
00:00 Introduction to the legislative landscape of cannabis
00:21 The impact of Charlotte's story on cannabis perception
00:48 Distinguishing hemp from marijuana in legislation
02:11 The challenges of passing therapeutic hemp laws
02:52 Congress's need for simple, effective regulation
03:48 The slow progress of therapeutic hemp legalization
04:53 The importance of clear plant distinctions
05:56 The November 12 hemp ban and its implications
07:02 The dangers of Franken hemp and synthetic cannabinoids
08:00 The public health emergency posed by recent bans
08:49 The role of science and data in regulation
10:13 The importance of industry and public unity
10:58 How regulations can support medical and adult use
12:06 The impact of federal bans on patients and consumers
13:00 The need for a balanced, science-based approach
14:00 The political landscape and legislative hurdles
14:53 The power of public advocacy and individual action
16:07 The future of cannabis regulation and industry alignment
17:06 How to effectively communicate with policymakers
18:03 The importance of clear, science-backed legislation
19:00 The role of the FDA and federal agencies
20:01 The potential for bipartisan support and progress
21:08 The significance of the November 12 deadline
22:06 The ongoing fight for access and regulation
23:04 The moral and ethical considerations in cannabis policy
23:49 How consumers can influence policy change
24:47 The importance of unity within the industry
25:46 The potential for a balanced, effective regulatory framework
27:06 The role of science and data in shaping policy
28:03 The need for responsible, clear regulations
29:02 The future outlook for therapeutic hemp and CBD
30:02 Final thoughts and call to action
Guest Links
https://www.coalitionforaccess.org/
https://www.instagram.com/paigefigi/
https://realmofcaring.org/about/paige-figi/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Understand This Before You Use AI To Build Software ft. Chris Guthrie
AI has made software easier than ever to build. That does not mean every internal tool should become the backbone of your business. In this episode, Bryan sits down with Chris Guthrie to break down the growing …
Show notes
AI has made software easier than ever to build. That does not mean every internal tool should become the backbone of your business.
In this episode, Bryan sits down with Chris Guthrie to break down the growing temptation inside cannabis companies to vibe code internal tools, dashboards, CRMs, ERPs, and operational systems in the name of saving money.
The problem is not the first version. The problem is what happens two months later, when a field does not map, the workflow breaks, the person who built it is unavailable, and a production team is now relying on code nobody fully understands.
Chris explains the difference between a useful AI-built prototype and an enterprise-grade system that can survive real operators, messy data, security needs, compliance, multiple departments, M&A diligence, and future FDA-style requirements.
This conversation covers why descriptive data does not create predictive insight, why Google Sheets to vibe coding can become a path to failure, and why the real AI opportunity starts after the business has clean data, clean processes, and a system strong enough to trust.
This episode covers:
- The weekend build that fails
- Descriptive data will not predict
- Clean books before M&A
Chapters
00:00 The Rise of AI in Software Development
03:07 Challenges of Internal Software Development
06:09 Understanding What 'Works' in Software
09:10 The Risks of Vibe Coding
12:05 The Importance of Established Infrastructure
14:58 Cost Considerations in Software Development
17:56 Predictive Insights and Data Utilization
21:13 Defining Core Business Focus
23:17 The Challenges of AI Implementation
27:00 Understanding AI's Limitations
28:58 The Importance of Data Governance
31:11 Navigating Change Management in Cannabis
35:51 Preparing for Industry Evolution
40:09 The ROI of ERP Systems
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Hirsh Jain: Rescheduling Is Already Picking Winners
Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.” States are interpreting rescheduling completely differently depending on their license structure. These tiny details are widening the gap …
Show notes
Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.”
States are interpreting rescheduling completely differently depending on their license structure. These tiny details are widening the gap between potential winners and losers.
In this episode, we break down what actually changed, what is still unresolved, and why rescheduling may already be picking winners and losers.
This week, we sit down with Hirsh Jain to discuss:
• What the April order and June 29 hearing actually mean
• How the DEA registration portal could impact operators
• The three pathways for interstate commerce
• Why state license structure may determine who is positioned for a national market
Chapters
00:00 Understanding Cannabis Rescheduling
02:53 The Implications of Medical vs. Adult Use Cannabis
05:48 Navigating Federal Legality for Medical Cannabis
09:03 DEA Registration: A New Era for Cannabis Businesses
11:53 The Complexities of DEA Registration
15:02 Interstate Commerce: The Future of Cannabis Trade
17:46 State Models and Their Impact on Cannabis Regulation
21:02 Winners and Losers in the Cannabis Market
24:04 The Role of Politics in Cannabis Regulation
27:01 The Future of Interstate Commerce in Cannabis
38:15 Understanding the Dormant Commerce Clause
40:46 Interstate Commerce and Political Friction
42:43 Legal Challenges to Cannabis Rescheduling
44:37 The April Order and Its Implications
51:05 Upcoming Hearings and Their Significance
59:22 Emerging Markets in Red States
01:05:34 Cultural Shifts and Legal Implications
01:10:16 Looking Ahead: Signals for Progress
Guest Links:
https://www.anandastrategy.com/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka
Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has. Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is …
Show notes
Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has.
Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire model. He thinks the opportunity starts there: trim the portfolio, stop chasing every trend, tighten the supply chain, lean on the science, and align operations. Germany's market could nearly double in the next two years, but capturing it will take more than expansion.
This week we sit down with James Yamanaka, CEO of Organigram:
- A BAT perspective on cannabis
- Why chasing every trend loses money
- How the Sanity deal unlocks Germany
Chapters:
00:00 Introduction to Organigram and BAT's Involvement
05:24 Shifting Perspectives: From BAT to Organigram
09:08 Understanding the Complexity of the Cannabis Market
13:12 Balancing Listening and Leadership
17:24 Data-Driven Decision Making in Cannabis
21:18 Strategic SKU Management and Market Forecasting
24:17 Leveraging BAT's Expertise in Cannabis
30:04 The Strategic Importance of the Sanity Deal
39:57 Navigating Regulatory Challenges in the Cannabis Industry
Guest Links:
- https://www.linkedin.com/in/james-yamanaka-aaa32a/
- https://www.organigram.ca/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry
When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more item to an already exhaustive …
Show notes
When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more item to an already exhaustive testing panel.
That logic is how licensed cannabis markets end up buried under compliance layers copied from other states, calibrated to someone else's problems.
It is also exactly how two adjacent markets with nearly identical consumer bases, Ohio and Michigan, ended up with completely different market structures.
What they do not share is regulatory philosophy. When one state watches another add a rule and asks itself whether it should do the same, the answer it lands on shapes the entire cost structure of every licensed operator inside its borders. Ohio learned to ask the follow-up question. Most states never do.
Ohio closed the intoxicating hemp loophole on March 20th, ahead of the federal government, and those shops are starting to close. The next unlock may already be here: THC beverages reaching the customers who will never walk into a dispensary, sold at the restaurant down the street.
This week we sit down with Caroline Henry, VP of Government and Regulatory Affairs at Buckeye Relief.
- The regulator FOMO problem
- Ohio vs. Michigan: two markets, one lesson
- THC beverages as the dispensary gateway
Chapters
00:00 The Disconnect in Cannabis Perception
03:12 Navigating Stigma and Misconceptions
05:48 Regulatory Challenges and Industry Standards
08:55 Building Relationships with Regulators
11:54 Small Wins in Regulatory Negotiations
15:02 The Impact of Over-Regulation
17:48 Child-Resistant Packaging and Its Irony
25:38 Navigating Regulatory Challenges in the Cannabis Industry
26:00 The Role of Beverages in Reducing Stigma
30:37 Learning from Michigan: Ohio's Cannabis Strategy
39:31 Focusing on Ohio: The Case for Local Expertise
44:00 The Realities of Working in the Cannabis Industry
Guest Links
- www.buckeyerelief.com
- www.amplifydispensary.com
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller
The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts …
Show notes
The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention.
CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could actually support. That gap created a backlash the legitimate medical thesis didn't deserve. What's left on the other side of the green rush is a near-complete forgetting of the reason this industry started in the first place. The medicine. Now the infrastructure to prove it is finally in place. Standardized genetics. Reproducible extraction. Full compound characterization. An FDA botanical drug pathway that has existed since 2016 that most investors have never heard of. Organic medicine versus synthetic single-molecule will be a real choice at the pharmacy counter sooner than most people expect. The foundational work is already here.
This week we sit down with Joel Stanley and Dr. Marcel Bonn-Miller:
- Botanical drugs vs. supplements
- 6,000 compounds, one drug
- Novel compounds nobody has named yet
Chapters
00:00 Why Medical Validation Remains a Challenge for Cannabis
00:12 The FDA Approval Process for Plant-Based Medicines
01:03 Historical Market Dynamics and Their Impact on Cannabis Perception
02:48 Removing the Veil: How Science Can Validate Cannabinoid Therapies
03:15 The Complexity of Plant Molecules and Real-World Evidence
06:20 Focus in Drug Development: The Case of Autism Spectrum Disorder
07:10 The Impact of Charlotte's Web and Media Hype
08:52 Balancing Hype and Reality in Cannabinoid Medicine
10:01 Legitimization of Cannabis Research in Academia
12:10 The Evolution of Cannabis Research and Acceptance
13:54 The Future of Botanical Medicine and Academic Research
16:15 The Long Road of Drug Development for Cannabis-Based Medicines
20:50 Introducing AJA-001: A Botanical Drug for Autism
22:44 Standardization and Characterization of Botanical Drugs
24:01 Partnerships and Funding in Botanical Drug Development
24:40 Challenges of Multi-Compound Botanical Drugs
27:28 Reproducibility and Quality Control in Botanical Manufacturing
29:06 FDA Pathways for Botanical Drugs and New Chemical Entities
34:29 Identifying and Characterizing Thousands of Plant Compounds
39:48 The Role of AI and Supercomputing in Drug Discovery
41:11 Balancing Exploration and Focus in Botanical Research
44:38 What the World Will Understand About Cannabinoids in 10 Years
47:24 The Promise of Botanical Medicine Over Single Molecule Drugs
Guest Links:
AJNA Biosciences Website
https://ajnabiosciences.com/AJNA Biosciences LinkedIn
https://www.linkedin.com/company/ajna-biosciences/posts/?feedView=allAJNA Biosciences Instagram
@ajnabiosciencesCharlotte’s Web Website
https://www.charlottesweb.com/Charlotte’s Web LinkedIn
https://www.linkedin.com/company/charlottesweb/posts/?feedView=allCharlotte’s Web Instagram
@charlotteswebcbdJoel Stanley LinkedIn
https://www.linkedin.com/in/joel-stanley-2885116b/Joel Stanley Instagram
@joel.stanleyDr. Marcel Bonn-Miller LinkedIn
https://www.linkedin.com/in/marcel-bonn-miller-897a581/Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Joe Lustberg: What Cannabis Lenders See That Operators Miss
The number in your head and the number you actually need are not the same number. That gap is where most cannabis businesses break. Joe Lustberg has financed operators across the country for years and watched …
Show notes
The number in your head and the number you actually need are not the same number. That gap is where most cannabis businesses break.
Joe Lustberg has financed operators across the country for years and watched that gap swallow businesses that looked fine on paper. He has also spent over two years paying rent on a Hamptons dispensary he cannot open because a municipality tried to rezone his property out from under him. The person telling you to build in 1.5X as your burn capital cushion has been living inside exactly the scenario he warns everyone about.
When the lender financing your industry has lived the same nightmare, the advice changes.
This week we sit down with Joe Lustberg, to discuss the following
- NY Regulatory Battlefield
- 280E Gone: What Changes
- Lending Specifics
Chapters
00:00 Navigating the Cannabis Landscape: A Personal Journey
02:51 Understanding the Financial Risks in Cannabis Operations
06:01 The Importance of Burn Capital for Cannabis Startups
09:02 Lending Dynamics in the Cannabis Industry
11:55 Market Trends and the Future of Cannabis Financing
14:51 The Impact of Rescheduling on Cannabis Operators
18:01 Identifying Strong Operators in a Competitive Market
21:05 Evaluating Financial Health: Key Indicators for Success
26:01 Evaluating Limited Markets: The Ohio Perspective
28:24 Navigating Unique Financing Requests
29:12 Surprising Success Stories in Cannabis Financing
32:04 The Importance of Experience in New Ventures
35:46 Identifying Undervalued Markets in Cannabis
38:00 The Future of Cannabis Markets and Interstate Commerce
Guest Links
https://www.linkedin.com/in/joseph-lustberg-23076722
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Hidden Margin Killer for MSOS ft. Braunz Muller
Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used to justify the wrong decision …
Show notes
Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used to justify the wrong decision. Overproduction cycles, steep discounting, margin pressure building back into manufacturing: most of that traces back to data being used reactively instead of as a decision guidance tool.
Layer on the reality of multi-state operations where every market runs a different system, tracks different items, and reports differently. Making sense of what the numbers are actually saying across that footprint isn't just a technology problem. It's an interpretation problem with real financial consequences.
Think of it like a compass that's slightly off calibrated. Over a short distance, no one notices. Across 15 facilities and hundreds of SKUs, you end up miles from where you intended.
This week we sit down with Braunz Muller, to discuss the following
- Margins in Cannabis Supply Chains
- Hydrocarbon SOP Secrets
- THC Efficiency as the Real KPI
Chapter
00:00 Data Problems in Cannabis Manufacturing
12:50 The Complexity of Decision-Making
20:31 Dynamic SOPs in Extraction
30:14 Balancing Flexibility and Control in Operations
32:08 Empowering Operators Within Structured Systems
35:03 The Importance of Data in Extraction
39:27 Understanding Yield and Efficiency
43:00 Closing the Loop in Extraction Processes
48:40 Optimizing Cultivation for Better Efficiency
54:04 Auditing for Efficiency in Manufacturing
56:51 The Future of Hydrocarbon Extraction Knowledge
Guest Links:
linkedin.com/in/braunz-muller-98382018b
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Ed Rosenthal and Greg Baughman: You're Still Growing Cannabis Wrong
A customer walks into the dispensary and asks the budtender for a flower recommendation. They end up with a degraded version of the once high-end flower that graced your cultivation floor. They do not know it …
Show notes
A customer walks into the dispensary and asks the budtender for a flower recommendation.
They end up with a degraded version of the once high-end flower that graced your cultivation floor. They do not know it. Your brand took the blame.
Ed Rosenthal, the most referenced name in cannabis cultivation history, says the cannabis supply chain has a freshness problem that starts in the dry room and compounds at every handoff. The smell of your drying room that everyone loves walking into? Those are your terpenes leaving the building.
This week we sit down with Ed Rosenthal and Greg Baughman to discuss:
How Canada already solved this
Why most are still cultivating wrong
Freeze drying vs. traditional dryingChapters
00:00 The Freshness Debate: Cannabis vs. Produce
03:01 Consumer Awareness and Dispensary Practices
05:55 Post-Harvest Processing: Ensuring Quality and Consistency
08:59 Innovations in Freeze-Drying Cannabis
11:48 The Science Behind Freeze-Drying: A Deeper Dive
14:52 Testing and Refining the Freeze-Drying Process
17:54 The Future of Cannabis Processing: Quality and Efficiency
28:28 Post-Harvest Efficiency and Cost Reduction
30:26 Cultivation Methods and Labor Costs
35:09 Crisis Management and Industry Change
39:22 Market Maturity and Operational Efficiencies
43:00 Future of Cannabis Cultivation
47:04 Innovations in Drying and Curing Processes
52:46 Consumer Perception and Quality Assurance
Guest Links:
- http://cryocure.com/
- https://www.linkedin.com/in/greg-baughman-2869b4218/
- https://www.linkedin.com/in/edrosenthal-/
- https://www.linkedin.com/company/cryocurecannabis/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli
The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap. Aubrey Amatelli left JP Morgan believing that if you followed the rules, aligned with …
Show notes
The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap.
Aubrey Amatelli left JP Morgan believing that if you followed the rules, aligned with card brand requirements, and structured things correctly, you could build a compliant, stable payment product. Then came Mastercard shutdowns, a failed tech partner that cost six figures, and a stretch where 5,000 dispensaries lost payment access in a matter of weeks. What came out of that was a different approach to building in cannabis. Redundancy is not a feature. It is the product.
This week we sit down with Aubrey Amatelli to discuss the following:
• JP Morgan to cannabis payments
• A failed partner and six figures lost
• Why moving from cash to card changes ticket sizeChapters
00:00 Navigating the Cannabis Payment Landscape
02:55 Understanding Payment Processing Challenges
05:57 Building Redundancies in Payment Solutions
09:02 The Impact of Federal Legislation on Payments
12:08 Consumer Education and Payment Solutions
15:03 Product Development and Market Needs
18:02 The Evolving Nature of Cannabis Payments
21:28 Navigating Cannabis Payment Solutions
22:12 The Rise of Cryptocurrency in Alternative Medicine
26:36 The Future of Cannabis Banking and Federal Legalization
30:22 AI's Role in Payment Processing
33:57 Understanding Payment Processing Challenges in Cannabis
37:10 The Importance of Average Ticket Growth
Guest Links
https://www.linkedin.com/in/aubreyamatelli/
https://payrio.co/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed
Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem. Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them …
Show notes
Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem.
Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them in the back, push them down the stairs, and take credit for the fall. It's time to put fear behind cannabis.
She spent 20 years on Capitol Hill. She's watched cannabis show up once a year for fly-ins, throw money at the wrong politicians, and wonder why nothing changes. This episode breaks down why incrementalism is the only path, why banking matters more than you think, and why the industry needs to stop picking out curtains when it hasn't built a basement.
This week we sit down with Gretchen Gailey:
- Stab them in the back politics
- Curtains before basement problem
- Project Champion playbook
Timestamps:
00:00 - The industry's fundamental misunderstanding about Washington politics
02:35 - Challenges with incrementalism versus desire for rapid change
04:47 - Supporting pro-cannabis politicians like Cynthia Loomis
06:45 - The role of education and public awareness campaigns
10:06 - Building a basic regulatory foundation: banking, safe products, and rescheduling
13:23 - The limitations of state-led models and the need for federal coordination
15:50 - The importance of transparency and federal standards for consumer safety
18:43 - The influence of political operatives and the importance of direct advocacy
22:51 - Using industry tools and data to inform policy and educate policymakers
26:15 - The significance of Congressional engagement and how to make cannabis an urgent issue
30:10 - The importance of political will and executive orders in advancing reform
34:40 - The disconnects within Washington and how industry can better influence policy
37:19 - Opportunities in leveraging symbolism like Veterans issues and Congressional events
41:14 - The disconnect between access and influence, and how to effectively make the case
44:40 - The necessity of creative strategies, public pressure, and celebrity involvement
50:21 - Successful stories: case of Cory Booker and the impact of direct constituent advocacy
52:16 - Final thoughts: how to stay engaged and educate the industry and policymakers
Summary:
In this episode, Gretchen Gailey shares over 20 years of experience navigating Washington's complex cannabis legislation. We explore how industry players can effectively engage with policymakers, the importance of foundational regulations, and strategies to accelerate federal progress on cannabis reform.
Guest Links:
- https://www.linkedin.com/in/gretchengailey
- https://projectchampion.org/
- https://x.com/GretchenGailey
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt
Investing in cannabis requires a split personality. Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that …
Show notes
Investing in cannabis requires a split personality.
Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that followed. His take: if you've been through multiple pump-and-dump cycles, you're not early anymore. You're just still here.
This is a masterclass in separating trader psychology from fundamental conviction. Dan explains why he keeps a small position just to stay seated, why he already knows he'll sell early on the next catalyst, and why the moment everybody's talking about cannabis on Wall Street Bets is the moment you size up — not before.
This week we sit down with Dan McDermitt:
- The "I'm early" delusion
- Why traders sell early
- Catalyst stacking thesis
- MSOS mechanics breakdown
Chapters
00:00 The Catalyst Dilemma in Cannabis
03:03 Trading Strategies and Market Positioning
05:48 Understanding Trader vs. Fundamentalist Perspectives
08:46 The Unique Nature of MSOS Trading
11:51 Market Dynamics and Trading Psychology
15:03 The Role of Uplisting and Rescheduling
18:08 Long-Term Perspectives in a Volatile Market
21:04 Risk Management and Trading Mindset
23:51 The Impact of AI on Trading Strategies
Summary
In this conversation, Bryan Fields and Dan McDermitt discuss the current state of the cannabis market, focusing on the challenges and opportunities within the sector. They explore the impact of potential rescheduling and uplisting on cannabis stocks, the differences between trading and fundamental analysis, and the unique trading dynamics of MSOS. Dan shares insights on risk management, trading psychology, and the influence of AI on trading strategies, emphasizing the importance of adapting to market conditions while maintaining a disciplined approach.
Guest Links:
- https://x.com/ChartGuys
- https://www.instagram.com/chartguys/
- https://www.youtube.com/@ChartGuys
- https://www.chartguys.com/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Premium vs Scale in Cannabis: Inside Rubicon’s Strategy ft. Margaret Brodie
Most cannabis companies chased scale. Rubicon chased quality. What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why consumers only give brands one …
Show notes
Most cannabis companies chased scale. Rubicon chased quality.
What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why consumers only give brands one chance, how Rubicon evaluates resource capacity and audits operations, and why Europe could become the next meaningful opportunity for their trusted brands.
This week we sit down with Margaret Brodie, CEO of Rubicon Organics:
• Why premium cannabis starts with flower
• Consumers Trust
• Internal Resource AuditsChapters
00:00 Quality Over Quantity in Cannabis
02:58 Building a Premium Cannabis Brand
05:47 Operational Excellence and Team Culture
09:04 The Pursuit of Continuous Improvement
11:45 Understanding Consumer Trust and Brand Loyalty
14:45 Strategic Decision-Making in Cannabis
18:06 Navigating Industry Challenges and Opportunities
27:55 Navigating the Fast-Paced Cannabis Industry
29:13 Investment Priorities for Growth
31:43 Strategic Market Expansion and Brand Development
35:08 Building a Lasting Brand in Cannabis
37:20 Learning from International Markets
40:56 Balancing Speed and Quality in Growth
42:51 Understanding Consumer Dynamics
46:06 Honoring the Legacy Market
49:30 Reflecting on the Journey and Future of Cannabis
Guest Links
https://www.instagram.com/rubiconorganics/
https://www.rubiconorganics.com/
https://x.com/RubiconOrganics
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Prop 64 Fine Print, Pesticide Drift, The Economics Behind Concentrates ft. Micah Anderson
When California legalized cannabis, did anyone see 70% of the state opting out. Retail access never recovered. The illicit market stayed durable. And taxes kept compounding pressure on operators. Micah …
Show notes
When California legalized cannabis, did anyone see 70% of the state opting out. Retail access never recovered. The illicit market stayed durable. And taxes kept compounding pressure on operators. Micah Anderson, CEO of LEEF Brands, explains how local bans strengthened the illicit market, why pesticide drift can wipe out millions in product, and why he is rebuilding a recovery and wellness push with NBA player Jimmy Butler.
This week we sit down with Micah Anderson:
- Pesticide drift killing millions
- Jimmy Butler recovery line
- Trump’s CBD signal
Chapters
00:00 Introduction: California Cannabis Market Challenges
00:31 Prop 64: A Poorly Executed Initiative
01:38 Local Politics and Industry Complexity
02:28 Fixing California Cannabis Policy
03:23 Industry Engagement and Advocacy
04:02 Reevaluating Prop 64 and Market Structure
05:02 Offense vs Defense in Industry Strategy
06:28 Changing Public Perception and Policy Reform
07:36 Industry Regulation and Taxation Issues
08:07 The Role of Advocacy and Industry Voice
09:19 Hindsight and Lessons Learned
10:41 Industry Participation in Policy Making
11:26 CBD and Medical Cannabis Opportunities
12:17 Brand Revival and Market Expansion
13:16 Supply Chain and Cultivation Strategies
14:09 Innovations in Wellness and Recovery Products
15:40 Educational Campaigns and Consumer Awareness
16:39 Research and Clinical Studies in Cannabis
17:08 Regulatory Barriers and Opportunities in Cultivation
18:12 Operational Challenges and Solutions
19:36 Medical Cannabis and Future Legislation
20:29 Supply Chain Management and Quality Control
21:31 Entry of New Participants and Industry Diversification
22:29 Market Expansion and Interstate Commerce
23:24 Pesticide Scrutiny as Industry Moat
24:22 Industry's Role in Consumer Safety and Transparency
25:29 Understanding Pesticide Regulations and Organic Standards
26:55 Supply Chain Variability and Farm Management
28:25 Cost and Efficiency in Cultivation
29:55 Sampling and Testing Challenges
31:33 Expanding Beyond California
33:50 Complexities of Concentrate Production
36:33 Yield Variability and Cultivation Nuances
38:20 Product Development and Customer Collaboration
40:54 Demand Planning and Market Forecasting
42:08 Data-Driven Decision Making in Extraction
44:24 Margins, Product Mix, and Client Relationships
45:47 Market Entry Strategies and Expansion
47:43 Future of Cannabis and International Markets
48:39 Bitcoin and Cannabis: An Evolving Relationship
51:30 Cryptocurrency as a Business Strategy
53:53 Future of Automation and Robotics in Cannabis Production
55:41 Contact and Follow-up
Guest links
https://www.linkedin.com/in/micah-anderson-leef/
https://leefbrands.com/about/
Resources
- LEEf Brands Website - https://leefbrands.com
- Elliot Lewis on Pesticide Regulations - https://twitter.com/ElliotLewis
- California Cannabis Regulations Overview - https://cannabis.ca.gov/regulations/
- Bitcoin Official Website - https://bitcoin.org
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
JB (Cheech & Chong CEO): Building a National Cannabis Brand Through Trial, Error & Partnership
Everyone knows the Cheech & Chong name. Almost no one understands the infrastructure behind it. This isn’t a celebrity brand story. It’s a leverage story inside a fragmented, state-locked cannabis market that …
Show notes
Everyone knows the Cheech & Chong name. Almost no one understands the infrastructure behind it.
This isn’t a celebrity brand story. It’s a leverage story inside a fragmented, state-locked cannabis market that could shift overnight.
While most operators vertically integrate and hope legislation cooperates, Cheech & Chong are building optionality. Reverse licensing, local partnerships, and asset-light expansion aren’t branding tactics , they’re positioning moves.
This week we sit down with Jonathan Black to discuss.
- How they are using reverse IP licensing
- MSO vs Big Tobacco
- Alcohol vs GLP-1 vs Hemp Beverages
Chapters
00:00 Introduction and Brand Infrastructure
00:10 JB's Vision for Cheech and Chong
01:07 Market Infiltration and Consumer Experience
02:20 Cheech and Chong's Brand Recognition and Growth
03:06 State-Level Strategies and MSO Dynamics
04:30 Building Ecosystems and Partner Collaboration
05:55 Shelf Space and Local Market Strategies
07:16 Establishing a National Brand in Cannabis
08:34 Trial and Error in Market Entry
09:02 Terpene Profiles and Product Consistency
10:01 Adapting to Different State Systems
11:12 Working with Dispensaries and Partners
12:08 Tools and Technology in Market Monitoring
13:24 Partnering with Celebrities and Influencers
14:23 Advertising Strategies and Consumer Awareness
15:17 Measuring Success and Market Penetration
17:37 Market Footprint and Future Opportunities
18:35 Expanding into New Markets and Countries
20:25 Product Launch Timing and Market Readiness
21:59 Exclusivity and Distribution Agreements
22:40 Managing State-Specific Regulations
23:07 Reverse Licensing Model Explained
24:42 Long-term Industry Outlook and Legislation
27:30 Industry Challenges and Opportunities
29:29 Big Tobacco and MSO Strategies
32:08 Hemp vs Cannabis Market Dynamics
34:14 Legislative Outlook and Industry Legislation
36:29 Cannabis as a Functional Beverage Alternative
38:42 Impact of Legislation on Market Growth
40:29 Celebrity Endorsements and Brand Building
42:31 Future Industry Scenarios and Opportunities
44:56 Getting in Touch and Industry Collaboration
Summary
In this in-depth interview, industry expert JB discusses the strategic growth of Cheech and Chong's brand in the cannabis and hemp markets, navigating state regulations, and the future of interstate commerce. Gain insights into brand expansion, licensing models, and industry challenges.
Guest Links:
- https://www.linkedin.com/in/jonathan-black-520a7a10/
- https://cheechandchong.com/
- https://www.forbes.com/sites/willyakowicz/2025/08/24/why-cheech-and-chongs-100-million-cannabis-empire-is-no-joke/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Cannabis Beverages Are Bringing New Consumers Into Cannabis ft Kristin & Eric Rogers
Beverage may be the most approachable format in cannabis.Familiar ritual. Familiar packaging. Familiar context. Easily Sharable But familiarity creates comparison.Alcohol.That means safety, expectation, and …
Show notes
Beverage may be the most approachable format in cannabis.
Familiar ritual. Familiar packaging. Familiar context. Easily Sharable
But familiarity creates comparison.
Alcohol.
That means safety, expectation, and education cannot be left to chance.
This week we sit down with Kristin and Eric Rogers of Levia to discuss:
• Beverage as a social format
• The responsibility of education
• Scaling experience across fragmented marketsChapters
00:00 Understanding Success in Cannabis Expansion
03:08 Brand Consistency Across State Lines
05:59 Targeting the Right Consumer Demographics
08:55 The Evolution of Cannabis Beverages
12:01 Navigating Dosage and Consumer Experience
15:02 Quality Control and Supply Chain Management
17:50 The Future of Cannabis and Alcohol Beverages
21:04 Educating Consumers and Regulators
24:07 Navigating Cannabis Regulations in Massachusetts
27:24 Understanding Cannabis vs. Alcohol: Safety and Impairment
31:10 The Impact of Cannabis on Alcohol Consumption
33:43 Educating Consumers: The Importance of Responsible Consumption
36:11 Packaging and Communication: Bridging the Knowledge Gap
40:04 Challenges in the Cannabis Industry: Patience and Perseverance
Summary
In this conversation, Bryan Fields and Kristin and Eric Rogers discuss the complexities of the cannabis beverage industry, emphasizing the importance of brand consistency, understanding consumer demographics, and navigating regulatory challenges. They explore the science behind cannabis beverages, the significance of dosage, and the potential future of combining cannabis with alcohol. The discussion also highlights the need for education and awareness among consumers and regulators, as well as the perseverance required to succeed in this evolving industry.
Guest Links
- https://levia.buzz/
- https://www.linkedin.com/in/eric-rogers12/
- https://www.linkedin.com/in/kristinhrogers/
- https://www.linkedin.com/company/leviabrands/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Hidden Growth Unmasked: Rescheduling, the Farm Bill & What Comes Next ft Trent Woloveck
For the last 18–24 months, reported cannabis growth told an incomplete story.Demand did not plateau.It was fragmented — between hemp channels, illicit markets, and regulated operators.Now, with the Farm Bill …
Show notes
For the last 18–24 months, reported cannabis growth told an incomplete story.
Demand did not plateau.
It was fragmented — between hemp channels, illicit markets, and regulated operators.Now, with the Farm Bill loophole closing, Virginia coming online, and rescheduling potentially closer to execution, the numbers begin to look different. And feel different.
This week we sit down with Trent Woloveck to discuss:
• Why leading with retail first changes everything
• The strategic tradeoffs of vertical integration
• What true cannabinoid demand actually looks like once distortion fadesChapters
00:00 The Value of Vertical Integration in Cannabis
04:52 Market Dynamics and Capital Allocation
09:34 Virginia's Cannabis Market Evolution
19:04 Impact of Federal Rescheduling on Cannabis
24:38 M&A Challenges in the Cannabis Industry
31:34 Navigating Regulatory Complexities
39:39 The Future of the Cannabis Market
47:27 Looking Ahead: Jushi's Future and Industry Changes
Summary
In this conversation, Bryan Fields and Trent Woloveck discuss the complexities of the cannabis industry, focusing on vertical integration, market dynamics, and the impact of federal rescheduling. They explore the challenges of capital allocation, the evolution of the Virginia cannabis market, and the difficulties of mergers and acquisitions in a heavily regulated environment. The discussion highlights the importance of understanding market demands and the potential for growth as the industry continues to normalize and expand.
Guest Links
- https://jushico.com
- https://www.linkedin.com/company/jushi-inc/
- https://x.com/two3king
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Most Cannabis Marketing Fails Because It Is Asked to Solve the Wrong Problems ft. John Shute
If you doubled your marketing spend tomorrow, would you double your sales?Most cannabis marketing does not fail because teams spend too little. It fails because marketing is asked to create success while known …
Show notes
If you doubled your marketing spend tomorrow, would you double your sales?
Most cannabis marketing does not fail because teams spend too little. It fails because marketing is asked to create success while known problems remain unfixed. That is why marketing is often the first thing cut when results stall.
What has changed is that modern tracking makes attribution clearer and easier than ever. Attribution means understanding which actions actually drive revenue, not just traffic or activity.
This week we sit down with John Shute to discuss:
• Why marketing gets blamed for upstream failures
• How attribution reveals what is actually working
• Where most teams are missingChapters
00:00 Navigating Budget Cuts in Cannabis Marketing
02:59 The Importance of Trackable Marketing Strategies
06:05 Understanding Consumer Behavior and Retention
08:53 Leveraging Data for Brand Growth
11:59 The Role of Email Marketing in Cannabis Brands
15:10 Product Quality and Consumer Safety
18:01 Narrowing Focus for Brand Success
23:26 Smart Growth Strategies in Cannabis Marketing
26:24 The Importance of Data-Driven Decisions
27:21 Closing the Gap: SEO and Market Positioning
30:27 Maximizing Marketing ROI
33:03 Understanding Marketing Attribution
36:14 Navigating Challenges in Client Relationships
39:19 The Complexity of Marketing in Cannabis
45:04 Community Engagement and Social Responsibility
Summary
In this conversation, John Shute discusses the challenges and strategies of marketing within the cannabis industry, particularly in the context of budget cuts. He emphasizes the importance of trackable marketing efforts, such as email marketing, and the need for brands to focus on consumer retention and data analytics. John also highlights the significance of building a strong brand identity and ensuring product quality and consumer safety. The discussion touches on the evolving landscape of cannabis marketing, the necessity for comprehensive audits, and the value of community engagement initiatives.
Guest Links
- https://x.com/johnshute_
- https://www.linkedin.com/in/john-shute-pufcreativ/
- https://www.instagram.com/pufcreativ/
- https://www.youtube.com/channel/UCY2pdmT1-QHKux8728PRy2A
- https://www.linkedin.com/company/pufcreativ
- https://pufcreativ.com/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
How Top Teams Balance Art and Process in Extraction ft. Brian Adams
Exceptional extraction has long been treated as an art.What separates the best teams is not creativity.It is the ability to repeat quality, consistently.And it is not SOP alone.It is judgment applied …
Show notes
Exceptional extraction has long been treated as an art.
What separates the best teams is not creativity.
It is the ability to repeat quality, consistently.And it is not SOP alone.
It is judgment applied consistently under real constraints. Constraints that define what is technically possible, operationally realistic, and economically viable.
Those constraints tart with understanding your system and tracking the right operational parameters at a level of detail most teams never reach.
That depth of understanding is what allows teams to produce a consistent, high-quality end product instead of relying on feel or memory.
This week we sit down with Brian Adams to discuss
- How to balance SOPs with operator flexibility
- How to think clearly about your extraction system and its limits
- Whether rolling back adult use in Massachusetts is real or noise
Chapters
00:00 The Complexity of Extraction Processes
03:06 Adapting SOPs for Optimal Results
06:04 Understanding Cost Structures in Extraction
09:12 The Importance of Hardware in Product Quality
12:07 Navigating Consumer Expectations and Feedback
15:10 Quality Control and Brand Reputation
18:11 Expanding Product Categories and Maintaining Standards
21:07 Educating Consumers on Concentrate Differences
23:56 The Future of the Cannabis Industry in Massachusetts
30:32 The Current State of Cannabis in Massachusetts
34:27 The Threat of Opposition and Industry Response
39:55 Navigating Negative Perceptions and Future Outlook
41:14 The Importance of Industry Unity and Consumer Education
42:29 Engaging with Consumers and Building a Brand
Summary
In this conversation, Bryan Fields and Brian Adams delve into the complexities of extraction processes in the cannabis industry, emphasizing the importance of flexibility in Standard Operating Procedures (SOPs) to achieve optimal results. They discuss the significance of understanding cost structures, the role of hardware in product quality, and the challenges of maintaining brand reputation amidst consumer feedback. The conversation also touches on the need for consumer education regarding concentrate differences and the potential future of the cannabis industry in Massachusetts. In this conversation, Brian Adams discusses the current challenges facing the cannabis industry in Massachusetts, particularly in light of recent negative news and opposition movements. He emphasizes the need for industry unity to combat misinformation and protect the rights of consumers. The discussion also touches on the importance of educating consumers about cannabis production and the potential impact of regulatory changes on the industry.
Guest Links:
https://www.nimbuscannabisco.com/https://www.nimbuscannabisco.com/
Our Links
- https://www.nimbuscannabisco.com/
- https://www.instagram.com/nimbuscc/
- https://www.linkedin.com/company/nimbus-cannabis-co/
- https://www.linkedin.com/company/hudson-botanical-processing/
- https://www.linkedin.com/in/jb-adams/
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Robotics vs Automation in Cannabis Manufacturing ft. Nohtal Partansky
Most cannabis automation fails for a simple reason.It optimizes motion instead of understanding.Automation executes. Robotics adapts.That distinction matters in an industry where variability is unavoidable and …
Show notes
Most cannabis automation fails for a simple reason.
It optimizes motion instead of understanding.Automation executes. Robotics adapts.
That distinction matters in an industry where variability is unavoidable and capital is limited.This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.
This week, we sit down with Nohtal Partansky to cover:
- Why automation breaks under variability
- Automation vs robotics, clearly defined
- How to avoid expensive missteps
Chapters
00:00 Understanding Automation in Cannabis Manufacturing
03:02 The Role of Robotics vs. Automation
05:45 Consultative Approach to Automation
08:54 Challenges in Cultivation Automation
11:59 Designing for Variability in Automation
15:01 Iterative Development and Customer Feedback
18:08 Identifying Design vs. Customer Issues
21:06 Adapting to Environmental Nuances
23:55 Conveying Value in Automation Solutions
27:09 Strategic Approaches to Automation in Supply Chain
30:10 Optimizing Pre-Roll Production Processes
33:44 Understanding Tolerance Levels in Manufacturing
36:39 Intellectual Property in the Cannabis Industry
42:26 Innovations in Cannabis Manufacturing
45:32 Challenges in Automation and Scaling
50:51 Improving Processes and Training in Cannabis Operations
Summary
In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.
Guest Links
- https://www.instagram.com/sortingroboticsinc/
- https://www.youtube.com/@sortingrobotics
- https://www.linkedin.com/company/sortingrobotics/
- https://www.sortingrobotics.com/
- https://www.linkedin.com/in/nohtal/
Our Links
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Building Jaunty Into One of New York’s Top Cannabis Brands ft. Nicolas Guarino
Jaunty’s rise to the top of the New York cannabis market was not an overnight success.It was built through discipline in a market uniquely designedNew York’s rollout remains unforgiving.One store openings …
Show notes
Jaunty’s rise to the top of the New York cannabis market was not an overnight success.
It was built through discipline in a market uniquely designedNew York’s rollout remains unforgiving.
One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.
This week we sit down with Nick to discuss:
Why consistency becomes the only real moat as prices fall
How New York’s rollout punished assumptions and rewarded preparedness
Capital discipline, supplier trust, and avoiding overspend death spirals
Chapters
00:00 Introduction to Jaunty and Nicolas Guarino
03:06 The Journey into the Cannabis Industry
06:07 Challenges and Lessons Learned in CBD
09:00 Transitioning to Recreational Cannabis
11:54 Building a Brand in a Competitive Market
15:07 Navigating Market Dynamics and Growth Challenges
18:07 The Importance of Support and Resilience
20:49 Understanding Market Economics and Consumer Behavior
23:55 Future Prospects for Cannabis in New York
31:48 The Economics of Cannabis Production
36:29 The Importance of Consistency in Branding
41:11 Navigating Challenges in Cannabis Operations
46:10 Strategic Planning for Future Growth
51:56 Inventory Management and Cost Control
56:02 Preparing for Market Consolidation
58:11 Final Thoughts and Future Directions
About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.
Summary
In this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.
Guest Links
- https://jaunty.com/
- https://x.com/getjaunty
- https://www.linkedin.com/company/get-jaunty
- https://www.instagram.com/get_jaunty/
- https://www.linkedin.com/in/nicolas-guarino-43939b103/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick
Before CBD was discussed by a President in the Oval Office, it was a medical necessity.The Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious …
Show notes
Before CBD was discussed by a President in the Oval Office, it was a medical necessity.
The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.
Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.
This week, we sit down with Bill Morachnick to break down:
- Why CBD earned acceptance through medical trust, not consumer marketing
- How physician comfort, reimbursement pathways, and standards changed the conversation
- CBD in the Oval Office — and what that signals for the future of cannabis
Chapters
00:00 Introduction to Charlotte's Web and Bill Morachnick
03:00 The Inspiring Story of Charlotte Figi
05:51 The Executive Order and Its Implications
08:59 The Role of Education in CBD Acceptance
12:12 Challenges and Misconceptions in the Cannabis Industry
15:03 The Future of CBD and Medical Recommendations
18:06 The Impact of Federal Reimbursement on CBD
21:08 Defloria and the Future of Cannabis Research
24:01 Navigating Regulatory Changes and Industry Challenges
27:03 The Importance of Quality and Consistency in CBD Products
30:02 The Potential for Pharmaceutical Collaborations
33:04 Looking Ahead: The Future of CBD and Cannabis
36:13 Final Thoughts and Audience Engagement
Summary
In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.
Guest Links:
- https://www.trycharlottesweb.com/
- https://www.charlottesweb.com/
- https://www.youtube.com/charlotteswebcbd
- https://www.instagram.com/charlotteswebcbd/
- https://www.linkedin.com/in/bill-morachnick-01318a6/
- https://www.linkedin.com/company/charlottesweb/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Playbook Behind Consistent Cannabis Products at Scale ft. Ryan Crandall
Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible.This week we sit down with Ryan Crandall, Chief Commercial …
Show notes
Everyone wants their product and brand to be known for consistency .
Almost no one is willing to do the difficult work that makes consistency possible.This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:
- Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts
- How MariMed engineers consistency across states by centralizing inputs & testing aggressively,
- What it actually takes to make effects-based products consistent and repeatable
Chapters
00:00 Introduction to the Cannabis Industry and Edibles
03:05 The Evolution of Edibles: From Early Days to Now
06:01 Ensuring Consistency Across State Lines
09:09 Quality Control and Testing in Edibles
12:01 Consumer Education and Brand Trust
15:13 MariMed Brand Portfolio and Market Strategy
18:06 Role of R&D in Product Development
21:00 Future Trends and Innovations in Edibles
24:03 Building Relationships with Budtenders and Consumers
27:58 Exploring Cannabinoids: THCV and CBG Effects
30:06 Understanding Edible Experiences and Consumer Expectations
32:00 Responsible Product Development in the Cannabis Industry
33:52 Brand Strategy and Market Penetration in New States
35:51 Innovative Products: Vibations and Consumer Convenience
38:04 Navigating the Hemp Market and Brand Expansion
39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis
44:02 The Importance of Team and Company Culture
Guest Links:
- https://www.marimedinc.com/
- https://www.linkedin.com/company/marimed-inc/about/
- https://www.linkedin.com/in/ryan-crandall-43133b12/
- https://x.com/MariMed_Inc
Summary
In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Schedule III Changes Everything — This Is Just the Beginning
Schedule III isn’t the finish line.It’s the starting gun.The EO said a lot — but most operators aren’t ready for what it actually means.This week we sit down with Zach Edge and Dr. Matthew Moore to break …
Show notes
Schedule III isn’t the finish line.
It’s the starting gun.The EO said a lot — but most operators aren’t ready for what it actually means.
This week we sit down with Zach Edge and Dr. Matthew Moore to break down:
- Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking
- What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators
- Which parts of the supply chain face the biggest disruption as cannabis moves forward
Chapters
00:00 Historic Changes in Cannabis Scheduling
03:13 The Impact of Hemp in the New Landscape
06:07 Strategic Shifts for Cannabis Operators
08:59 Navigating Regulatory Changes
11:58 The Role of Pharmacies in the New Market
15:04 Global Trade and Competition in Cannabis
17:53 Research Opportunities and Challenges
21:02 Veterans and the Future of CBD
24:02 The Supply Chain Dynamics
26:47 The Future of Hemp and CBD Products
29:56 Final Thoughts on the Cannabis Industry
Summary:
In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.
Guest Links:
- https://www.linkedin.com/company/the-rho-advisory/
- https://www.linkedin.com/in/zach-edge/
- https://www.linkedin.com/in/mmoore09/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Inside SNDL’s Hidden Scale: Global Reach & Supply Chain Powerhouse ft. Tyler Robson
SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply …
Show notes
SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.
This week we sit down with Tyler Robson, President of SNDL, to break down:
• How SNDL became a global manufacturing and retail powerhouse
• Why extraction and derivatives are their true competitive edge
• How they operate across countries with completely different rules and product formatsChapters
00:00 Introduction to Sundial and Tyler Robson
02:08 The Complexity of Extraction and Manufacturing
04:38 Merging Sundial and Valens: Challenges and Strategies
06:11 Sundial's Operations and Global Reach
07:39 Firefighting and Problem Solving in Leadership
09:52 Data-Driven Decision Making
12:44 Navigating Different Regulatory Environments
13:55 Core Competencies and Operational Efficiencies
15:46 Staying Focused in a Distracted Industry
16:18 Sundial's Market Position and Brand Partnerships
17:10 Strategic Focus on Texas and Florida
19:09 Resource Planning and Flexibility
20:42 Continuous Improvement in Manufacturing
22:34 Synergies Between Liquor and Cannabis
24:48 Future of Cannabis and Liquor Co-Mingling
26:30 Emerging International Markets
28:23 Potential Partnerships and Collaborations
30:08 The Size of the Global Cannabis Opportunity
31:31 Strategic Partnerships in the US
32:03 Conclusion and Key Takeaways
Summary
In this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.
Guest Links:
- https://sndl.com/homepage/default.aspx
- https://www.linkedin.com/in/tyler-robson-a77ba4155/
- https://www.linkedin.com/company/sndlinc/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
These are the latest 40 of 309 episodes. You’ll find older episodes in the podcast’s feed.
Similar podcasts
More Business podcasts
Is this your podcast?
Confirm it with an entry in your feed: you get a code here, add it as podcast:txt to the channel of your feed, and we check it. Your podcast is then shown as “verified” on SoundNode.